Accretion Nutraveda IPO
Nutraceuticals / Healthcare - Listed on 04 February 2026
Accretion Nutraveda IPO listing summary
Accretion Nutraveda (Nutraceuticals / Healthcare) closed its IPO window in 2026 and listed on NSE and BSE on 04 February 2026 at an upper band issue price of Rs 129, opening at Rs 191 for a listing gain of +48.1% and closing day one at Rs 191.2 (+48.2% on closing basis). The IPO was subscribed 1.91x overall - QIB 1.01x, HNI/NII 2.42x, Retail 2.19x. The total issue size was Rs 24.77 Cr (Fresh Issue Rs 24.77 Cr, OFS Rs 0 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Listing day performance
Subscription breakdown
Final (Day 3) subscription
Number of times each investor category subscribed by close of Day 3.
Day-wise overall subscription
How overall subscription built up across the three-day issue window.
Accretion Nutraveda IPO GMP history
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | - | - |
| Day 2 | - | - |
| Day 3 | - | - |
| Day 4 | - | - |
| Day 5 | - | - |
Issue & financials
Market context at listing
How the broader market moved around the Accretion Nutraveda IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Accretion Nutraveda IPO - FAQs
What was the listing gain of Accretion Nutraveda IPO?
Accretion Nutraveda IPO listed at +48.1% versus the upper issue price of Rs 129 on 04 February 2026.
How many times was Accretion Nutraveda IPO subscribed?
Accretion Nutraveda IPO was subscribed 1.91x overall. QIB portion was subscribed 1.01x, HNI / NII 2.42x and Retail 2.19x.
What was the IPO GMP for Accretion Nutraveda?
Day-by-day IPO GMP data for Accretion Nutraveda is listed in the table above.